Objectives: To determine the antimicrobial susceptibility of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae causing community-acquired lower respiratory tract infection in the UK during 2002/2003 and to compare susceptibilities determined locally by disc diffusion with agar dilution MICs determined at a central laboratory.
Introduction
The main bacterial causes of lower respiratory tract infection (RTI) are Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. H. influenzae that are b-lactamase-positive are common in the UK, 3 Europe and the USA, 4 and co-amoxiclav-resistant isolates have been reported. 4 Resistance to penicillin in pneumococci is now a worldwide problem 5, 6 and multi-resistance is common in these strains. 5 Most isolates of M. catarrhalis are also b-lactamase producers. The increasing antimicrobial resistance in respiratory pathogens highlights the need for alternative agents for the treatment of respiratory infections. In this study, the in vitro activity of a range of agents against routinely isolated pathogens causing community-acquired lower respiratory tract infection in the UK was investigated.
Resistance surveillance studies including different laboratories may be based on susceptibility testing carried out locally in the participating clinical laboratories, or the isolates may be collected centrally for testing by a reference method in one laboratory. The latter has the advantages of greater standardization of methodology and the use of quantitative methods, whereas the former is less likely to be restricted in the number of isolates tested. 7 No study of RTI isolates has investigated comprehensively whether centralized testing with a quantitative reference method produces significantly different resistance rates from local testing by a standardized disc diffusion method (although a comparative study was carried out in 1990 before development of the BSAC standardized disc diffusion method 8 ). Such a comparison was made in this study as all isolates were tested locally by the BSAC standardized disc diffusion method and centrally by the BSAC agar dilution method.
Materials and methods

Antimicrobials
The following antimicrobials were obtained from their respective manufacturers: moxifloxacin, ciprofloxacin (Bayer, Newbury, UK), levofloxacin, clarithromycin (Aventis Pharma, Romainville, France), linezolid (Pfizer, Sandwich, UK), co-amoxiclav (clavulanic acid from GlaxoSmithKline, Harlow, UK and amoxicillin from Sigma, Poole, UK). Erythromycin, ampicillin, penicillin G, cefuroxime, cefotaxime, tetracycline and trimethoprim were obtained from Sigma. These antimicrobials were used for susceptibility testing by the BSAC agar dilution method. 9 Discs containing the same antimicrobials (except oxacillin replaced penicillin G) with contents as required for the BSAC disc diffusion method 10 were purchased from Oxoid (Basingstoke, UK). Ampicillin and co-amoxiclav were tested against H. influenzae and M. catarrhalis only. Trimethoprim and penicillin G (oxacillin) were tested against H. influenzae and S. pneumoniae only, respectively.
Collecting laboratories and isolates
Thirty collecting laboratories throughout the UK (24 in England, three in Scotland, two in Wales and one in Northern Ireland) were asked to collect up to 50 isolates from cases of community-acquired lower respiratory tract infection as follows: H. influenzae (20), S. pneumoniae (20) and M. catarrhalis (10) from between September 2002 and March 2003. Isolates from patients admitted to hospital were also included, but only if from specimens taken within 48 h of admission. Duplicate isolates from the same patient were excluded. The following demographic data were also collected: patient gender, patient age and specimen type.
Local laboratory disc diffusion susceptibility testing
All collecting laboratories determined the antibacterial susceptibility of isolates by the BSAC disc diffusion method. 10 Before this, each centre was sent six organisms (three S. pneumoniae, two H. influenzae and one M. catarrhalis) to test as a quality assurance exercise to ensure that results were acceptable before commencement of testing of clinical isolates.
Central laboratory isolate identification and MIC determination
Collected isolates were sent to a central testing laboratory (GR Micro Ltd) where they were re-identified using standard procedures, as described previously.
11 H. influenzae and M. catarrhalis were tested for the presence of b-lactamase (nitrocefin, Oxoid, Basingstoke, UK). MICs of antibacterial agents were determined by the BSAC agar dilution method. 9 MICs were interpreted into categories of susceptibility according to BSAC breakpoints (Table 1) . 9 The following reference strains were used for quality control: Escherichia coli ATCC 25922, Haemophilus influenzae ATCC 49247, Streptococcus pneumoniae ATCC 49619 and Staphylococcus aureus 29213.
Results
Patient demographic data
Isolates from a total of 1369 patients were included in the study, 713 patients were male, 655 were female and gender information was not provided for one patient. Antibacterial activity was similar for isolates from patients of different genders (data not shown).
The age of patients was provided for 1364 isolates. Numbers of isolates from patients in the three age groups 18-64 (48.1% total), > _ 65 years (44.1% total) and < 18 years (7.8% total) were, respectively, H. influenzae 290, 264 and 26; M. catarrhalis 105, 134 and 28; S. pneumoniae 261, 204 and 52. The antibacterial MIC profiles for isolates from patients in the three age groups were indistinguishable (data not shown).
The vast majority of isolates submitted for inclusion in this study were from sputum (93.0%), the next most prevalent sources were nasopharyngeal aspirate (2.6%), bronchoalveolar lavage (1.8%) and blood (1.2%). Numbers of isolates from sources other than sputum were too small to analyse any possible relationship between source of isolate and antibacterial susceptibility.
Susceptibility of Haemophilus influenzae by MIC determination
All MIC results for the relevant reference strains were within one two-fold dilution of the target MIC. 9 A total of 581 H. influenzae were collected by local laboratories and all were re-confirmed as H. influenzae at the central laboratory. The MIC distributions of the test antimicrobials against H. influenzae are shown in Table 2 and susceptibility rates in Table 3 .
By the reference MIC method, almost 15% of H. influenzae were resistant to ampicillin (Table 3) , which correlated with the presence of b-lactamase in 86 (14.8%) isolates. As would be expected, there was a lower rate of resistance to co-amoxiclav (5.8%). However, 33 of the 34 isolates that were resistant to coamoxiclav were only borderline resistant. For 27 of these, the co-amoxiclav MIC was 2 mg/L (nine being b-lactamase positive and 18 b-lactamase negative) and for six isolates, the co-amoxiclav MIC was 4 mg/L (two b-lactamase positive and four b-lactamase negative). All 22 b-lactamase-negative isolates resistant to co-amoxiclav were susceptible to ampicillin, although both co-amoxiclav and ampicillin MICs were borderline resistant and susceptible, respectively, in most cases (data not shown). The single co-amoxiclav-resistant isolate with an MIC of 8 mg/L was also resistant to ampicillin (MIC 4 mg/L). Although not positively confirmed, this isolate is likely to be b-lactamase-negative, ampicillin-resistant. Resistance to cefuroxime was found in 14.5% of isolates, but none was resistant to cefotaxime Table 1 . BSAC MIC and zone breakpoints for H. influenzae, M. catarrhalis and S. pneumoniae ( Table 3 ). The distribution of MICs was considerably lower for cefotaxime than for cefuroxime (Table 2 ). Macrolide susceptibility rates for H. influenzae were very low ( < 1%), but the majority of non-susceptible isolates were of intermediate susceptibility to clarithromycin or erythromycin (Table 3 ). All three fluoroquinolones showed a similar MIC distribution, with ciprofloxacin being generally slightly more active than levofloxacin, which in turn was slightly more active than moxifloxacin (Table 2) . Nevertheless, susceptibility for all fluoroquinolones was 100% (Table 3) . Susceptibility to tetracycline also approached 100% (Table 3 ) but resistance to trimethoprim was found in around 14% of isolates (Table 3) .
Susceptibility of Moraxella catarrhalis by MIC determination
All MIC results for the relevant reference strains were within one two-fold dilution of the target MIC. 9 Overall, 269 isolates of M. catarrhalis were collected by local laboratories and all were re-confirmed as M. catarrhalis at the central laboratory. The MIC distributions and the susceptibility rates are included in Tables 4 and 5 , respectively.
b-Lactamase was produced by 252 (93.3%) isolates of M. catarrhalis which correlated with resistance to ampicillin (86.6%). Apart from this, and 10.4% cefuroxime resistance, there was little evidence of reduced antibacterial susceptibility in M. catarrhalis isolates ( Table 5) .
Susceptibility of Streptococcus pneumoniae by MIC determination
All MIC results for the relevant reference strains were within one two-fold dilution of the target MIC, except that the moxifloxacin MIC for S. pneumoniae ATCC 49619 was consistently 0.12 mg/L, rather than the documented target of 0.5 mg/L. 9 Our results are in keeping with the expected moxifloxacin MIC for susceptible pneumococci.
Five hundred and nineteen isolates of S. pneumoniae were collected by local laboratories and all were re-confirmed as S. pneumoniae at the central laboratory. The MIC distributions and susceptibility rates are shown in Tables 6 and 7 , respectively. The highest rate of resistance among the S. pneumoniae isolates was 11.8% to both macrolides (Table 7) . Resistance to cefuroxime, 2 ciprofloxacin and tetracycline was around 5%. Although only a small percentage of isolates were fully resistant to penicillin (0.8%), a larger proportion (6.6%) were intermediate (Table 7) . No linezolid-resistant isolate was found (Table 7) and, as with H. influenzae, no resistance to cefotaxime was seen.
Moxifloxacin was considerably more active against S. pneumoniae than ciprofloxacin or levofloxacin ( Table 6 ). The rate of resistance to moxifloxacin was slightly lower than that for levofloxacin (Table 7) . Although the MIC distributions for levofloxacin and ciprofloxacin were quite similar (Table 6) , no ciprofloxacin-susceptible isolates were recorded because only intermediate or resistant categories are available for ciprofloxacin with the BSAC breakpoints.
Susceptibility determined centrally by agar dilution MIC compared with susceptibility determined locally by disc diffusion Correct susceptibility reports for all tests were returned by all participating laboratories for the six quality assessment strains distributed before testing clinical isolates. Tables 3, 5 and 7 show a summary of susceptibility data determined centrally by an agar dilution method and locally by the 30 collecting laboratories using BSAC disc diffusion methodology for H. influenzae, M. catarrhalis and S. pneumoniae isolates, respectively. In total, 785 disagreements (i.e. where local disc susceptibility did not agree with central MIC determination susceptibility) occurred out of a total of 14 281 susceptibility determinations. This equates to an overall discrepancy rate of 5.5%. Of these, 352 (2.5%) were major disagreements (i.e. resistant by one method but susceptible by the other) and 433 (3.0%) were minor disagreements (i.e. resistant or susceptible versus intermediate) ( Table 8 ). In general, there was good correlation between susceptibility results obtained at local laboratories and those obtained at the central laboratory. The biggest disagreement between the two testing methods occurred with macrolides tested against H. influenzae, which showed a 23.2% discrepancy with clarithromycin and 40.9% discrepancy with erythromycin (Table 8) . Almost all of these discrepancies were minor, with isolates intermediate in susceptibility to erythromycin (236 isolates) and clarithromycin (128 isolates) by MIC being classified as fully resistant by disc diffusion. False erythromycin resistance with M. catarrhalis tested by the disc diffusion method was also observed (Table 8 ) but 15 out of the 19 isolates were borderline resistant (zone diameters 26-27 mm).
There was also notable disagreement between the two methods with cefuroxime for both H. influenzae and M. catarrhalis (Table 8) . With H. influenzae, the disc diffusion method underestimated resistance, but 51/72 of these isolates were borderline resistant (MIC 2 mg/L). With M. catarrhalis, disc diffusion tests overestimated resistance, but 50% of these isolates were borderline resistant (zone diameter 18 -19 mm). Disagreements occurred with ampicillin against H. influenzae and M. catarrhalis (Table 8) . If b-lactamase results are used to predict ampicillin susceptibility there was only one MIC error (one M. catarrhalis isolate being b-lactamase-negative but ampicillin-resistant). Some false resistance of H. influenzae to coamoxiclav by disc diffusion testing was noted (Table 8) ; but all 12 isolates falsely reported susceptible by disc diffusion were borderline resistant by MIC (2 mg/L) and 18/26 isolates falsely reported resistant by disc diffusion were borderline resistant on zone diameter (15-16 mm).
Screening for penicillin resistance in S. pneumoniae by the oxacillin disc diffusion method produced disagreements with MIC results for 49 isolates (9.5%), the majority of these being minor (Table 8) . Thirty-two of the 34 minor disagreements were with isolates that were resistant by the oxacillin screen but borderline intermediate by penicillin MIC (1 mg/L). In addition, 9/15 of the major disagreements were with isolates that were resistant by oxacillin disc screening results but borderline susceptible by penicillin MIC (0.06 mg/L).
Results by the two susceptibility testing methods with linezolid, trimethoprim and fluoroquinolones were highly comparable except for 5.8% minor disagreements with ciprofloxacin against S. pneumoniae (Table 8) , and all these discrepancies were between intermediate and resistant as the BSAC has no susceptible category for this combination.
Discussion
This study evaluated the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial isolates from 30 centres within the UK. The results show that antibacterial resistance among these isolates in the UK is relatively low compared with other countries and regions throughout the world, as determined by recent global surveillance studies. [4] [5] [6] Furthermore, antibacterial susceptibility has not altered to any great extent over the last 12 years in the UK, apart from a reduction in tetracycline resistance in S. pneumoniae and H. influenzae and an increase in b-lactamase in H. influenzae and M. catarrhalis.
12,13
In this study, the macrolide class of antimicrobials showed poor potency against H. influenzae, and S. pneumoniae were less susceptible to macrolides than to the other antimicrobials tested. Cephalosporins showed varied activity, with cefotaxime being more active than cefuroxime. Penicillin G and tetracycline nonsusceptibility in S. pneumoniae was high relative to other nonmacrolides and ampicillin activity was compromised against M. catarrhalis and H. influenzae due to the presence of b-lactamases. The presence of b-lactamase did not affect the activity of co-amoxiclav, as would be expected. For b-lactamase-negative H. influenzae, ampicillin MIC was generally one dilution lower than co-amoxiclav MIC. As both antibacterials have identical breakpoints, this may be the cause of minor anomalies with those isolates being ampicillin-susceptible but co-amoxiclavresistant.
The fluoroquinolones levofloxacin and moxifloxacin were consistently active against respiratory pathogens with moxifloxacin being the more active of the two against S. pneumoniae. In accordance with this, the MIC results for these fluoroquinolones against the reference strain S. pneumoniae ATCC 49619 were 0.12 and 0.5 -1 mg/L for moxifloxacin and levofloxacin, respectively. However, the BSAC reference document states targets of 0.5 mg/L for both fluoroquinolones. We therefore suggest that the target for moxifloxacin against S. pneumoniae ATCC 49619 should be re-evaluated. Both fluoroquinolones showed similar activity against H. influenzae or M. catarrhalis. Linezolid resistance was not found, but this agent is restricted to Gram-positive infections only.
Since 1999, the BSAC has coordinated a respiratory tract surveillance study within the UK and Ireland with 20 centres supplying isolates to a central laboratory for testing by the BSAC agar dilution MIC method.
3 Nine out of the 30 centres enrolled in this study also participate in the BSAC study but the remaining 21 centres are not involved. Data from the BSAC surveillance study are available online as an interactive database. Table 8 . Disagreement in susceptibility determined by disc diffusion and agar dilution MIC methods Number (%) susceptibility disagreements This enables direct comparisons to be made between this study and the BSAC surveillance study over the same period. The MIC distributions for the two studies are almost identical. The second objective of this study was to compare susceptibilities determined locally at the collecting laboratories using BSAC disc diffusion methodology and those determined by BSAC agar dilution MIC testing at a central laboratory. Collecting laboratories were screened in a quality assessment exercise before enrolment to ensure that they were competent in carrying out the BSAC disc diffusion methodology. The comparison between results from the collecting laboratories and the central testing laboratory was encouraging because there was little difference in results using either BSAC method. Furthermore, the majority of the disagreements that did occur were caused by borderline susceptibility results from one or other testing method. This indicates that any hospital laboratory accurately using BSAC disc diffusion methods can compare their local results directly with larger surveillance studies based on the BSAC agar dilution method, such as this current study and the BSAC surveillance programme. It may also be possible to compare local results with surveillance studies using other testing methods, as has been demonstrated with the NCCLS microbroth dilution method.
14 Nevertheless, care must be taken with some antimicrobials because breakpoints can differ significantly between methods. For example, NCCLS co-amoxiclav breakpoints for H. influenzae are susceptible < _ 4 mg/L and resistant > _ 8 mg/L. 15 With these breakpoints, only 0.17% of isolates are resistant, compared with 5.85% with BSAC breakpoints.
Despite the good correlation between the BSAC agar dilution MIC and disc diffusion methods, one specific anomaly has been highlighted where a substantial proportion of H. influenzae isolates with intermediate susceptibility to erythromycin and clarithromycin by MIC were classified as resistant by disc diffusion. Erythromycin and clarithromycin MICs for many of the isolates were close to the intermediate-resistant breakpoint concentrations of > _ 8 and > _ 16 mg/L, respectively. The breakpoints for macrolides in the BSAC method are adjusted to report most H. influenzae as intermediate in susceptibility as most isolates form a unimodal distribution of intermediate susceptibility.
Hence it would appear that the BSAC disc diffusion method is falsely reporting resistance in this study. Problems with testing macrolides against H. influenzae are well known and often relate to the use of CO 2 during incubation. 16, 17 While the use of CO 2 enhances bacterial growth it also antagonizes macrolide activity by reducing pH. Both BSAC methods require an atmosphere of 4-6% CO 2 during incubation of H. influenzae 9,10 so any effects of CO 2 should be consistent for the two methods, although it is possible that the two susceptibility methods differ in their response to CO 2 .
Problems with correlation of BSAC agar dilution MIC and disc diffusion methods have been described with Pseudomonas aeruginosa, where poor correlation between the BSAC MIC and disc diffusion methods has been reported, especially with meropenem. 18, 19 In addition, a recent study of 3378 blood culture isolates, including Enterobacteriaceae, Acinetobacter spp., pseudomonads, staphylococci and enterococci, showed that susceptible results by the BSAC disc diffusion method were generally confirmed by full MIC determination. 19 However, disc diffusion tended to over-report resistances, particularly with some strains having borderline susceptibility to some agents. It was notable that most of the discrepancies investigated were discounted when disc diffusion tests were repeated in the reference laboratory, indicating errors in testing in the local laboratories rather than problems with the method. Such a critical examination of correlation of MIC and disc diffusion has not been published for other methodologies and guidelines.
In conclusion, this study showed that rates of resistance among community-acquired respiratory tract isolates were relatively low in the UK, as seen in other studies. Moxifloxacin was the only antibacterial with over 99% isolates susceptible for each of the three pathogens investigated where breakpoints are available. The comparison between disc susceptibility testing and agar dilution MIC determination by BSAC methods generally showed good correlation but highlighted a methodological problem with the testing of macrolides against H. influenzae by disc diffusion which resulted in intermediate strains frequently being reported resistant.
